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Allele copy number determination <p>A new protocol for using molecular inversion probes to specifically and accurately measure allele copy numbers.</p>
Abstract
We have developed a new protocol for using molecular inversion probes to accurately and
specifically measure allele copy number. The new protocol provides for significant improvements,
including the reduction of input DNA (from 2 μg) by more than 25-fold (to 75 ng total genomic
DNA), higher overall precision resulting in one order of magnitude lower false positive rate, and
greater dynamic range with accurate absolute copy number up to 60 copies.
Background
Chromosomal copy number analysis has been important in
the study of tumor samples for decades. Changes in copy
number have already been demonstrated to predict patients'
response and/or prognosis [1], which gives hope that this can
be applied in large scale to significantly affect clinical care in
the future. In order to fulfill this promise, technologies that
are able to assess copy number on the whole genome scale in
a large number of samples are required. Since the develop-
ment of comparative genomic hybridization (CGH) [2], many
technologies have been developed to address this need. These
include bacterial artificial chromosome (BAC) CGH and,
more recently, CGH employing several types of oligonucle-
otides arrays [3-7]. Some of the newer CGH methodologies
allow for allelic information to be obtained [4,5,7,8]. The util-
ity of measurement of allele copy number (ACN) includes the
identification of loss of heterozygosity (LOH) events [4] and
the allelic composition at amplified loci [9].
One of the techniques that have previously been described for
the measurement of ACN is molecular inversion probes
(MIPs) [10-12]. Briefly, MIP probes are circularizable oligo-
nucleotides, where the two ends carry two sequences that are
complementary to two sequences on the genome separated by
one nucleotide (exactly where the variant to be genotyped is).
After hybridization to the genomic DNA, the reaction is split
into four tubes where a single nucleotide is added to each
tube. Upon the addition of the nucleotide, the MIP probe is
ligated closed (but this only occurs in the tube with the
nucleotide that is complementary to the allele on the
genome), turning the probe into a circle. This structure can be
selected for by the use of exonucleases, allowing for minimal
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'cross talk' between probes and making it possible to obtain
high quality data from highly multiplexed assays (>50,000-
plex). Ultimately, these products are amplified and hybrid-
ized onto an Affymetrix microarray to identify the present
products.
The MIP assay differs from other highly multiplexed (tens of
thousands to hundreds of thousands) genotyping techniques
in that it utilizes enzymatic steps in solution to capture spe-
cific loci, which is then followed by an amplification step.
Such a combination of enzymatic steps confers a high degree
of specificity on the MIP assay. The high specificity and min-
imum 'cross talk' between loci or alleles results in precise
measurements as well as large assay dynamic range. In addi-
tion, the amplification of the loci of interest only simplifies
the task of detection and provides the ability to use lower
amounts of input genomic DNA. The high precision, large
dynamic range, and low DNA usage are demonstrated in this
study. Finally, because MIP requires only 40 base-pairs of
intact genomic DNA, its use in degraded samples, such as for-
maldehyde fixed paraffin embedded samples, may offer dis-
tinct advantages.
We have made significant advancements in this technology.
As a result, the false positive rate has decreased by an order of
magnitude and the dynamic range extended to achieve accu-
rate absolute copy number measurements up to 60 copies,
while reducing the input genomic DNA requirement by more
than 25-fold.
We describe the performance of the MIP assay using several
types of metrics that are broadly useful to all copy number
assays: the ability to discriminate a copy number aberration
from normal at the total as well as ACN level; and the ability
to accurately quantify the level of copy number aberration at
both the total and ACN levels.
Results
MIP copy number assay modification
We have previously described the use of MIP for copy number
analysis [11,12]. We have now improved the performance of
the technology through modifications of the MIP copy
number protocol and through improved data analysis. The
improved performance allows ACN data to be obtained using
75 ng of human genomic DNA.
The first implementation of the MIP ACN assay required 2 mg
of genomic DNA. We discovered that only a fraction of the
genomic templates hybridized to MIP probes that are then
circularized and amplified. We hypothesized that increasing
the number of MIP molecules and decreasing the hybridiza-
tion volume should increase the number of MIP molecules
bound to their genomic targets. We tested this hypothesis and
verified that increasing the number of MIP molecules by a
factor of four and decreasing the hybridization volume (from
27 ml to 6.7 ml) allowed us to substantially decrease genomic
DNA input. After the hybridization, buffer is added to
increase the volume to 27 ml, and the rest of the protocol is
unmodified.
In the standard genotyping protocol, the genomic target is
split into four reactions, where one of each of the four nucleo-
tides is added. We recognized that we could decrease DNA
input requirements by performing a smaller number of these
reactions We reasoned that if we were to use only one set of
single nucleotide polymorphisms (SNPs; for example only the
most common C/T SNPs), we would decrease the DNA
requirement by 50%. Similarly, adding two nucleotides into
each of two reactions leads to the same result. We have imple-
mented this variant protocol by adding G and C nucleotides
into one tube, and adding A and T into another. In this sce-
nario, about 85% of SNPs in the human genome (all but G/C
and A/T SNPs) can be assessed. An advantage of decreasing
the number of reactions is that it requires only two independ-
ent readouts rather than four (that is, four colors on one array
or one color on four arrays). In the optimized procedure, 75
ng of genomic DNA are mixed with more than 50,000 probes
in a small volume (6.7 ml). The hybridized probe:target
genomic DNA are split into two reactions, where two nucleo-
tides are added to each of the two tubes. The two reactions are
processed separately and read on two independent arrays,
which was found to yield better data than two colors on one
array (data not shown).
One effect that requires correction in quantitative assays on
arrays is the phenomenon of saturation. This is especially
important for correct estimations of amplifications. We have
implemented a Langmuir correction for the non-linear rela-
tionship between signal and copy number [13]. Our algorithm
was developed on a separate data set, and the data shown
here is an independent set. Using this algorithm we have been
able to measure copy number in a linear fashion at levels over
60 copies (see below).
Detection of aberrations
An important aspect of the copy number performance is the
detection of aberrations where the copy number is distinct
from 2. The degree of discrimination between copy number 2
and the aberrant copy can be understood through receiver
operator characteristic (ROC) curves showing the trade off
between false positive rate and sensitivity (1 - false negative
rate) given data on regions with known copy number. The
presence of cell lines carrying 1, 3, 4, or 5 X chromosomes pro-
vides a good resource for the study of the performance of the
technology in this copy number range [2]. For example, in the
assessment of cell lines with one X chromosome (males) one
can make a threshold at copy number 1.5 and any marker on
the X chromosome with a copy number below 1.5 would be
considered a true positive, and any autosomal marker with a
copy number below 1.5 is considered a false positive. By plot-
ting this trade off between true and false positives at manyhttp://genomebiology.com/2007/8/11/R246 Genome Biology 2007,     Volume 8, Issue 11, Article R246       Wang et al. R246.3
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thresholds between copy numbers of 0 to 3, the full ROC
curve is generated.
To assess the ability of MIP to detect copy number aberra-
tions we used a probe panel containing approximately 53,000
SNPs. We utilized this pool to assay 63 samples (45 unique, 9
duplicate) from the 3 major populations used in the HapMap
project. Out of the 53,341 SNPs, 50,806 had genotyping call
rates of greater than 90%. We then sorted the remaining
SNPs based on the standard deviation of their predicted copy
number. We selected the most robust markers for detailed
study of copy number performance by selecting those with a
standard deviation of less than 12%. This yielded a population
of 39,785 markers. Figure 1 shows the copy number estimates
across the genome for the different samples carrying one to
five copies of the X chromosome. By assuming that males
have only one copy of the X chromosome markers and two
copies of autosomal markers, we generated ROC curves to
describe the trade off between false positive rate and sensitiv-
ity for distinguishing one copy from two copies (Figure 2, red
line). Similar ROC curves can be generated for the discrimi-
nation between 2 and 3, 4, or 5 copies (Figure 2). Comparing
the generated ROC curves with our published data for the
previous MIP protocol, we find a dramatic improvement. For
example, at the same 50% sensitivity level, we found a reduc-
tion of the false positive rate by an order of magnitude.
The ROC curve above describes the average performance of a
set of samples. We also wished to understand the perform-
ance of individual samples. As can be seen in Figure 3, indi-
vidual samples have different false positive rates given the
same sensitivity level.
Similarly, ROC curves can be generated to assess the ability to
study ACN. For example, Figure 4 depicts the ROC curve to
assess the ability to discriminate the usual 1:1 ratio in hetero-
zygotes from the 2:1 ratio on the X chromosome in a cell line
carrying 3X chromosomes. The ROC curve for allele ratio is
not as good: at a sensitivity level of 50%, the copy number
false positive rate is approximately 1 × 10-3, and the allele
ratio false positive rate is approximately 8 × 10-3. One reason
for this discrepancy is that we are using the best markers as
defined by copy number root square deviation. The use of the
best markers as defined by an allele ratio criterion (allele ratio
root square deviation) significantly improves the perform-
ance (sensitivity of 50% and false positive rate of approxi-
mately 3 × 10-3.
Systematic false positives
The above analysis assumes that all the autosomal markers
are present at two copies per cell. There has been a wealth of
evidence demonstrating copy number polymorphisms
(CNPs) in the general population [14,15]. Therefore, a frac-
tion of what we considered as false positives may in fact be
true positives. In addition, the presence of a secondary SNP
(distinct from the one being interrogated) within the probe
may emulate the presence of a deletion. Data generated on
two CEPH pedigree populations, Yoruban and Utah, are
informative in this regard because the polymorphisms on
which the MIP panel is based are from European (equivalent
to Utah) rather than African populations. The contribution of
genetic variants (CNP or SNP) to the apparent false positive
rate is suggested by our detection of approximately three-fold
more apparent autosomal deletions in the Yoruban popula-
tion compared to the Utah population (average number of
markers per sample with measured copy number below 1.3 is
126 markers for the Utah population and 319 for the Yoruban
population). We hypothesized that this imbalance between
the number of apparent deletions in the two populations was
likely due to secondary polymorphisms close to the SNP being
assayed, which prevent proper binding of the MIP to its tar-
get. Further evidence to support this hypothesis was noted
when we observed that the majority of these apparent dele-
tions were reproducible when a sample is re-assayed.
To understand the nature of these apparent deletions, we ran-
domly picked nine SNPs, which showed copy number meas-
urements below 1.3 in replicate measurements from the
Yoruba sample (sample NA18515). We PCR amplified
approximately 400 base-pair fragments that included the
SNP assayed by MIP and used dideoxy sequencing to show
that eight of these nine loci that were successfully sequenced
had a secondary SNP within the MIP probe homology
sequence. The ninth SNP that showed copy number 1 was
assayed by qPCR to measure copy number but was found to
show a normal copy number of two (Supplementary Table 1 in
Additional data file 1).
Trade off between resolution and performance
Copy number changes are expected to occur in discrete seg-
ments, allowing neighboring markers to be averaged
together. This leads to enhanced performance as measured by
the trade off between false positive rate and sensitivity (that
is, the ROC curve moving to the upper left) at the expense of
lower resolution.
As discussed above, one shortcoming of the ROC analysis is
the presence of CNPs in the autosomes. Averaging two adja-
cent markers that lie within a CNP will erroneously consider
these markers as false. Therefore, for the purpose of describ-
ing the performance of the technology, we averaged markers
that are not adjacent to each other. This method would amel-
iorate the effect of miscalling two adjacent markers in a CNP
as a false positive. This analysis is appropriate as long as there
is a lack of correlation between marker performance and the
position on the chromosome. If this assumption is true, then
the operation reflects the performance of averaging two adja-
cent markers since the adjacent and the random markers are
obtained from the same distribution. Clearly, averaging data
from non-adjacent markers is valid only for the assessment of
the technology performance and cannot generate any mean-
ingful biological findings.Genome Biology 2007, 8:R246
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Averaging over two markers improves the performance of the
MIP data significantly (Figure 5). Clearly, when one is trying
to obtain biological information, smoothing non-adjacent
markers is totally erroneous. In this case we were interested
in the exact opposite: erasing any real biological information
(copy number polymorphisms) and, hence, we smoothed
across non-adjacent markers. For the discrimination between
1 and 2 copies, a sensitivity level of 80% and a false positive
rate of 5 × 10-5 can be achieved.
The ROC curves shown in the above figures describe the per-
formance of the top approximately 75% of the markers in the
Genomic view of samples with 1-5X chromosomes Figure 1
Genomic view of samples with 1-5X chromosomes. The X axis shows the markers in a genomic order, with each chromosome uniquely colored. The Y 
chromosome depicts the measured copy number for each marker in linear scale. The X chromosome is the last chromosome on the right and is shown in 
orange. (a) A male sample with 1X chromosome. (b) A female sample with 2X chromosomes. (c) A cell line with 3X chromosomes. (d) A cell line with 
4X chromosomes. (e) A cell line with 5X chromosomes.
(a)
(e)
(d) (c)
(b)http://genomebiology.com/2007/8/11/R246 Genome Biology 2007,     Volume 8, Issue 11, Article R246       Wang et al. R246.5
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panel we constructed. It is expected that as more of the lower
quality markers are considered, the ROC performance will
decrease. We included approximately 48,000 markers
(approximately 90% of the total) in the analysis. Figure 5
shows the ROC curve to discriminate one from two copies
using one marker or two markers using 75% (40 K) or 90%
(48 K) of the data. As can be seen in Table 1, the average per-
formance with 90% of the markers is somewhat worse than
that seen with 75% of the markers when judging the specifi-
city at 50% sensitivity.
Accuracy of copy number estimation
The ROC curves describe the discrimination between two
copies and a specific aberration. However, they do not define
the accuracy of the copy number estimation. The accuracy of
the copy number determination can be estimated by the devi-
ation from the true copy number. This can be readily meas-
ured for one to five copies using the X chromosome series. As
can be seen in Table 2, the copy number estimation in the MIP
data is very close to the true value. The precision, as defined
by the relative standard deviation, over the one to five copy
number range is 0.1-0.14.
Accuracy of copy number estimation at high copy number
amplification can be assessed by comparing the MIP
estimation with real time PCR measurement. We have done
such a calibration for a selected amplification in cell line
MCF7 (Figure 6). The average copy number estimate among
30 MIP markers within the amplification is 43, which is close
to the 33 copies measured by real time PCR. Copy number
estimation is computed relative to a 'control' region in the
genome. In cancer cell lines, the 'control' region used in real
time PCR may not have the average ploidy of the cell and,
therefore, may bias the estimation of the amplified region. In
fact, in this example the control region was from chromosome
2, which is estimated to be present at slightly elevated copy
numbers compared to the average of the genome based on the
MIP data. Correcting for this bias would make the MIP and
real time PCR copy number estimation of the amplification
even closer.
To carefully assess the accuracy of the measurement at high
copy number values, we added a known quantity of a set of
PCR amplicons to a normal sample before the MIP reaction
was performed. The DNA fragments that were spiked in were
ROC analysis Figure 2
ROC analysis. The x-axis is the rate of false positives (in log10), computed as the proportion of autosomal markers that have copy number below any given 
threshold (for the 1X calculation). The y-axis depicts sensitivity, defined as the proportion of X chromosome markers that have copy number values below 
the same threshold (for the 1X calculation). The curve is generated by calculating these values at many different thresholds. The curves from the 3X, 4X, 
and 5X cell lines were generated in an analogous fashion.
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added at different copy number levels ranging from no extra
copies to several hundred additional copies. Supplementary
Table 2 in Additional data file 1 shows the PCR amplicons, the
MIP probes they correspond to, and the spike in levels. We
show the relationship between the expected and the meas-
ured copy number of the individual spikes in Figure 7.
The accuracy of measurement of ACN in amplification sites
for many methods is limited by allele cross talk. Allele cross
talk is the proportion of signal measured for one allele in the
presence of a second allele. To assess this phenomenon using
MIPs, we studied the spike in data. The spiked in PCR ampli-
cons were purposely generated from an individual that is
homozygous and added into DNA from a heterozygous indi-
vidual, making the copy number for one allele 1 and the other
ranges from 1 to 1,000. The allele cross talk in the MIP assay
is very low, as the presence of 100 copies or more of one allele
does not change the copy number of the other allele signifi-
cantly (Table 3).
Identification of LOH without matched normal tissue
A major challenge in the study of ACN is the absence of
matched normal tissue for many valuable clinical samples. In
tumors that have lost one allele, it is not easy to discriminate
LOH for individual alleles that are homozygous in the entire
individual. We recognized that the high sensitivity and accu-
racy of the MIP ACN assay, coupled with the high likelihood
of normal tumor contamination, could allow us to distinguish
LOH from alleles that are homozygous. In theory, this should
be best accomplished with tumor showing substantial
(approaching 50%) normal contamination.
To test this theory, we analyzed ACN from five breast tumors
using the 60 K MIP panel. Visual examination of the data
clearly show a typical plot of estimated copy number for allele
A versus allele B, compared to a tumor with relatively normal
genome structure (Figure 8a). Three clusters are expected in
such a plot, one at ~2, 0 (homozygous A), one at 0, ~2
(homozygous B), and one at ~1, ~1 (heterozygous). In the
aberrant tumor samples (Figure 8b,c), three distinct clusters
can be observed in the heterozygous cluster. The central clus-
ter represents the 'true' heterozygous copy number measure-
ments. The flanking clusters represent LOH of either the A or
B allele. These sub-clusters of the heterozygous cluster clearly
resolve into discrete copy number segments along the chro-
m o s o m e ,  a s  c a n  b e  s e e n  i n  F i g u r e  9 .  W e  a r e  a l s o  a b l e  t o
observe that deletions are observed not as zero copies for each
allele, but as about 0.5 copies of each allele (Figure 9d). To
ROC analysis for individual samples Figure 3
ROC analysis for individual samples. The x-axis is generated in the same fashion as Figure 2, except that the curve for each sample is plotted separately. 
The average curve is the thick black line.
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assess reproducibility, we analyzed all samples in duplicate
and calculated concordance estimates for the various geno-
types (Table 4).
Discussion
We describe in this manuscript significant improvements we
have made to the MIP-based measurements of ACN. By
increasing the proportion of genomic targets that are hybrid-
ized to the MIP probes, we have improved the performance
while requiring a smaller amount of DNA. Additionally, for
copy number measurements there are substantial advantages
in uniformity and robustness when utilizing one-color read-
outs, especially at high levels of multiplexing. The use of a
control sample that is co-hybridized with the test sample in
an analogous fashion as used by BAC arrays leads to inferior
results compared with the one color readout (data not
shown). Presumably, this is because the different dyes have
different characteristics of brightness and saturation. We
conclude that the effect of the lack of uniformity among the
dyes is probably larger in our system than chip-to-chip varia-
tion that the control sample co-hybridization is supposed to
ameliorate. The improvements achieved from the new proto-
col as evaluated by ROC curve analysis resulted in a decline in
the false positive rate by an order of magnitude, while reduc-
ing the input genomic DNA by more than 25-fold. In addition,
the dynamic range has been extended with accurate estima-
tion achieved for up to 60 copies.
We evaluated the performance of MIP for ACN measure-
ments using a set of metrics that are broadly useful for all
copy number assays. We demonstrate the ability of MIP to
detect a single copy deletion or duplication at an allele and
total copy number levels using ROC curve analysis. We
believe ROC curve analysis provides a rigorous statistical
framework for comparing different technologies or different
protocols/algorithms of the same fundamental technology. In
addition to genuinely improving the technology performance
in the ROC curves by the use of better protocol and algo-
rithms, one may apparently improve them by smoothing (Fig-
ure 5), or filtering the worst markers (Figure 5) or the worst
samples (Figure 3).
We have shown in the single MIP marker analysis that many
of the apparent false positives in the discrimination between
1 and 2 copies are due to the presence of SNPs in the genomic
ROC analysis for allele ratio Figure 4
ROC analysis for allele ratio. The x-axis is the rate of false positives (in log10), computed as the proportion of autosomal markers that have allele ratio 
above a threshold. The y-axis depicts sensitivity, defined as the proportion of X chromosome markers in the cell line carrying 3X chromosomes that have 
copy number values below the same threshold. The curve is generated by calculating these values at many different thresholds.
0
0.2
0.4
0.6
0.8
1
1.2
0.0001 0.001 0.01 0.1 1
False positive rate (log)
S
e
n
s
i
t
i
v
i
t
yGenome Biology 2007, 8:R246
http://genomebiology.com/2007/8/11/R246 Genome Biology 2007,     Volume 8, Issue 11, Article R246       Wang et al. R246.8
sequence that are complementary to the MIP probes. This
effect will be strongest in populations that are the most
diverse. It should be possible to ameliorate this effect by using
matched normal and tumor pairs. The presence of SNPs may
explain why the discrimination between 1 and 2 is not better
than that between 2 and 3, as secondary SNPs that interfere
with MIP binding emulate a copy number deletion.
We also show the MIP assay precision of measurements of
copy number at allele and total copy number levels. Precision
at the total copy number level requires low background of the
assay and lack of saturation. In addition, allele level precision
requires a low level of allele cross talk even when one allele is
present in huge excess relative to the other.
These observations led us to suspect that it should be possible
to genotype mixed DNA populations, such as occurs in tumor
samples contaminated with normal tissue. As normal con-
tamination increases, some estimate of the amount of normal
contamination is valuable, which we believe can be quite
ROC analysis for two-marker smoothing Figure 5
ROC analysis for two-marker smoothing. The same ROC analysis as described in Figure 2 was performed here using the same set of markers (~40 K) as 
well as using a larger number of markers (~48 K). The ROC analysis was also performed using two-marker smoothing. In this case the smoothing was 
done for two random markers. If we assume that the performance of individual markers is not correlated with their position (that is, markers close 
together are likely to have similar performance), then this should be an accurate reflection of the resultant performance with adjacent marker smoothing. 
We note that at the lower false positive rate for the two-marker smoothed data, the curve is not smooth given low statistics.
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Table 1
Sensitivity at 50% specificity
One marker Two markers
40 K (75% of data) 1.7E-03 4.0E-05
48 K (90% of data) 2.7E-03 7.1E-05http://genomebiology.com/2007/8/11/R246 Genome Biology 2007,     Volume 8, Issue 11, Article R246       Wang et al. R246.9
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accurately estimated using the calculated copy numbers for
regions of LOH and deletion.
One promise of ACN data over the traditional total copy
number data is the potential that it may facilitate the identifi-
cation of the critical genes in regions of aberrations. Even
though large aberrations can be readily identified by total
copy number CGH, the identification of the critical gene(s) in
these aberrations is often not straightforward. This is in con-
trast to sequencing data where identification of mutations has
been quite laborious, but once achieved the critical gene is
usually easily identified. Identification of an allele that is pref-
erentially deleted or amplified in a set of samples implicates
the specific allele (or one in linkage disequilibrium with it) as
critical in the pathogenesis of the aberrations.
Materials and methods
Samples and MIP assay
The normal samples as well as the samples carrying 3
(NA04626), 4 (NA01416), and 5(NA06061) copies of the X
chromosome were obtained from Coriell Cell Repository
(Camden, NJ, USA). The normal HapMap samples that were
used were also obtained from Coriell Cell Repository. The
samples that were used were: NA19240, NA19239, NA06991,
NA06985, NA19238, NA19222, NA19202, NA19201,
NA19200, NA19132, NA19131, NA18956, NA18951,
NA18949, NA18947, NA18945, NA18912, NA18854,
NA19130, NA19128, NA19127, NA19099, NA19094,
NA18991, NA18987, NA18981, NA18605, NA18603,
NA18582, NA18573, NA18558, NA18550, NA18547,
NA18542, NA18537, NA18515, NA18508, NA12892,
NA12813, NA12717, NA12156, NA12155, NA12004, NA11881,
NA11840, NA11832, NA11830, NA10831, NA07345,
NA07056, NA07029, NA07019, NA07000, and NA06993.
The MCF7 cell line was obtained from the American Tissue
Cell Culture (ATCC, Manassas, VA, USA).
The MIP assay was performed as described previously, but
with important modifications [10]. Specifically, the current
protocol is a modification of the targeted genotyping protocol
commercialized by Affymetrix (additional information about
Table 2
Expected versus measured copy number
Expected copy number Measured copy number Relative standard deviation
1 (9) 1.055 0.14
2 (15) 1.997 0.12
3 (2) 3.104 0.11
4 (2) 3.981 0.10
5 (2) 4.956 0.10
Values in Parentheses represent the number of replicates measured.
Amplification in MCF7 Figure 6
Amplification in MCF7. (a) The x-axis shows the markers in a genomic order, with each chromosome uniquely colored. The y-axis depicts the measured 
copy number for each marker in log2 (the log scale is used given the high dynamic range). The arrow depicts the position of the locus that was also 
analyzed by real time PCR. (b) Focused view around the amplification site that was checked with real time PCR. As can be seen, there are several sites of 
amplifications of different levels. The black bar identifies the region for which average copy number was calculated.
(a)
Copy
number
(log2)
(b)
Copy
number
(log2)
Genomic order Genomic orderGenome Biology 2007, 8:R246
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MIP technology can be found at the Affymetrix website [16]).
Briefly, test DNA samples were diluted to 16 ng/ml. All DNA
quantification was done using PicoGreen dsDNA Assay Kit
(Molecular Probes/Invitrogen, Carlsbad, CA, USA, P7589).
We used 96- or 384-well plates whenever possible to reduce
variation. For day1 overnight annealing, 4.7 μl of DNA sam-
ples (75 ng total), 0.75 μl of Buffer A, 1.1 μl of the 53 K probe
pool (200 amol/μl/probe) and 0.045 μl of Enzyme A were
mixed well in a 384-well plate on ice. The reaction was incu-
bated at 20°C for 4 minutes, 95°C 5 minutes, then 58°C over-
night. On day 2, 13 μl of Buffer A was added to each well with
1.25 μl of Gapfill Enzyme mix. Then, 9 μl of this was put in
each of two wells in a 96-well plate. MIP probes were circular-
ized with 4 μl of dinucleotide (dATP with dTTP, dCTP with
dGTP) and mixed at 58°C for 10 minutes. The uncircularized
probes and genomic DNA were eliminated by addition of 4 μl
of Exonuclease Mix and incubation at 37°C for 15 minutes,
followed by heat-killing of enzymes. The circularized probes
were linearized by the addition of Cleavage Enzyme Mix at
37°C for 15 minutes, then subjected to universal primer
amplification for 18 cycles at 95°C for 20 s, 64°C for 40 s and
72°C for 10 s. For the labeling reaction, the product was fur-
ther amplified with the label primers for 10 cycles, and then
subjected to cleavage by Digest Enzyme Mix at 37°C for 2 h.
To hybridize, the cleaved MIP products were mixed with
hybridization cocktail, denatured and hybridized to 70 K Uni-
versal Taq arrays at 39°C for 16 h (two arrays per sample). The
overnight hybridized arrays were washed on GeneChip® Flu-
idics Station FS450 and stained by SAPE at 5 ng/ml
(Invitrogen).
Estimation of copy number of the spikes Figure 7
Estimation of copy number of the spikes. The x-axis shows the expected copy number (in log2) for the individual spiked in PCR fragments, and the y-axis 
shows the observed copy number for the same spiked in fragments. The linear fit (r2 = 0.82) is only for spikes with expected copy number <64 (26) 
because of the clear saturation above that point.
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Copy number estimation was obtained from the hybridization
signals as described previously, but with the following
modifications [10]. Given that in this work no multi-color rea-
dout was present (but rather single color readout on two
arrays), no spectral overlap was present and, therefore, the
color-seperation step was omitted. In addition, instead of the
linear calibration of the allele signals, Langmuir correction
was done [13].
Generation of spike-in samples
A panel of 80 PCR products representing genomic regions
containing MIPs on chromosome 2 were PCR amplified from
CEPH1341.14 (NA06985) using an ABI 9700 thermocycler
(initial denaturation of 95°C for 5 minutes, 95°C for 30 s,
58°C for 30 s, 72°C for 60 s for 30 cycles; final extension at
72°C for 7 minutes). The products were purified using a Min-
Elute 96 UF PCR Purification plate (Qiagen Valencia, CA,
USA) and resuspended in TE. The purified products were
quantified on a fluorometer using the Quant-It™ dsDNA
Assay kit (Invitrogen). Purified PCR products were then
pooled into ten tubes, each containing eight different prod-
ucts (Supplementary Table 2 in Additional data file 1). Each
pooled tube of probes was then serially diluted two-fold into
a series of spike-in tubes containing 150 ng of genomic DNA
from CEPH1341.02 (NA06991) (Supplementary Table 2 in
Additional data file 1). The genomic DNA samples were cho-
sen so that the spike-in PCR products from CEPH1341.14 rep-
resented a single allele, while the genomic DNA from CEPH
1341.02 was heterozygous, allowing for discrimination of
allele specific amplification.
Table 3
Allele copy number in spiked samples
Copy_A Copy_B
199.2 1.3
184.8 1.1
169.4 1.5
141.8 1.3
139.7 0.8
105.4 1.0
84.6 1.0
80.2 0.9
73.8 0.8
73.0 0.9
70.6 1.1
64.5 1.0
60.8 1.0
59.8 1.3
57.4 0.8
54.6 1.1
52.8 1.0
43.3 0.8
39.2 1.1
38.8 0.9
33.4 0.8
27.5 0.8
25.7 0.9
18.7 1.2
14.3 0.7
12.9 0.9
11.3 1.0
ACN distributions and reproducibility Figure 8
ACN distributions and reproducibility. (a) Copy number measurements 
for tumor sample 47 (fairly normal genome content) with genotypes AA 
colored red, AB colored blue, and BB colored green. (b, c) Allele copy 
number measurements for tumor 45 (replicate 1). (b) Genotypes derived 
from replicate 1 are colored AA red, AB blue, and BB green; (c) the 
genotypes from replicate 2 in the same color scale.
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Sequence analysis of aberrant MIPs
PCR products were amplified using primers designed to span
sequences containing MIPs that did not hybridize as expected
(Supplementary Table 1 in Additional data file 1).
Amplification was carried out in a 50 μl reaction (initial dena-
turation of 95°C for 5 minutes, 95°C for 30 s, 58°C for 30 s,
72°C for 60 s for 30 cycles; final extension at 72°C for 7
minutes) and products were purified using a MinElute 96 UF
PCR Purification plate (Qiagen) and resuspended in TE. The
purified products were sequenced using an Applied Biosys-
tems (Foster City, CA, USA) 96 capillary 3730 × l DNA Ana-
lyzer and the forward and reverse primers used during
amplification.
Visualization of individual copy number measurements without matched normal samples Figure 9
Visualization of individual copy number measurements without matched normal samples. (a-c) Copy number measurements for tumor 48 in genome 
order from chromosome 1 on the left to chromosome 22 and X on the right. Data are segregated by higher and lower copy number estimates and by 
homozygosity or heterozygosity. Blue and orange data points are the higher allele copy measurement while green and red data points are the lower copy 
number measurements. Blue and red data points are homozygous alleles while orange and green are heterozygous alleles. (a) The entire genome. (b) 
Chromosome 1 through the first 100 Mbp of chromosome 5. (c) Chromosome 1 and the first 50 Mbp of chromosome 2, showing key features of ACN 
data: an amplification is seen near position 5e7; an extra copy of 1q is seen between ~1.5e8 and 2.5e8; a deletion of 1 copy is seen on the p arm of 
chromosome 2 between ~2.5e8 and 3e8 (observed in (b) as a complete loss of one copy of chromosome 2). (d) A small section of chromosome 5 from 
tumor 44. One chromosome is at copy number 0.5 across this region, which indicates a loss of that chromosome. The black arrow shows a region at total 
copy number 2, which likely includes reduplication of the lost chromosome in the tumor. The red arrow shows a region where both alleles are at copy 
number 0.5, suggesting a complete deletion. The green arrow shows copy number 1 for the yellow alleleshttp://genomebiology.com/2007/8/11/R246 Genome Biology 2007,     Volume 8, Issue 11, Article R246       Wang et al. R246.13
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Identification of LOH without matched normal tissue
Genotyping metrics from the traditional MIP method were
applied to each observation and estimated genotypes (AA,
AB, or BB) were determined for each MIP in each of five rep-
licated tumor samples. Data are provided as Additional data
file 1. Regions of the genome that show clear evidence for
decreases in copy number are easily observed with the
decrease in copy number equivalent to 1.5 total copies (1 copy
of 1 allele and 0.5 copies of the other, or for homozygous
alleles 1.5 total copies). No regions of the genome in any of the
five samples analyzed appear to have ~1 copy of the higher
allele and ~0 copies of the lower allele.
Abbreviations
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